Insiders · Profile

Mor George Adi

Chief Executive Officer at Chemomab Therapeutics. Filing since 16 Nov 2022. CIK 0001851069

Company

Date

Role

Action

Amount

Of holding

29 May 2026

Chief Executive Officer

Sold at will

9,804

$20.25K

6.8%

3 Jan 2023

Chief Scientific Officer

Sold, plan not stated

7,700

$38.71K

2.4%

3 Jan 2023

Chief Scientific Officer

Sold, plan not stated

6,100

$30.66K

2.4%

16 Nov 2022

Chief Scientific Officer

Sold, plan not stated

324,775

$677.09K

50.0%

16 Nov 2022

Chief Scientific Officer

Sold, plan not stated

257,248

$536.31K

50.0%

5 decisions on file.